Tilray Brands (TLRY) has launched Tilray Medical-branded cannabis flower products in the UK through its Lyphe Clinic and Lyphe Dispensary, the company said Monday.
Tilray Brands acquired Lyphe Group in April, which it said ties together Tilray Medical's production network with Lyphe's patient and pharmacy infrastructure.
Shares of Tilray Brands were up close to 2% pre-bell.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments